Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 236

1.

A single intramuscular injection of neuraminidase inhibitor peramivir demonstrates antiviral activity against novel pandemic A/California/04/2009 (H1N1) influenza virus infection in mice.

Bantia S, Kellogg D, Parker C, Upshaw R, Ilyushina NA, Babu YS.

Antiviral Res. 2011 Apr;90(1):17-21. doi: 10.1016/j.antiviral.2011.02.001. Epub 2011 Feb 21.

PMID:
21316393
2.

Intravenous peramivir inhibits viral replication, and leads to bacterial clearance and prevention of mortality during murine bacterial co-infection caused by influenza A(H1N1)pdm09 virus and Streptococcus pneumoniae.

Onishi M, Kitano M, Taniguchi K, Homma T, Kobayashi M, Yoshinaga T, Naito A, Sato A.

Antiviral Res. 2015 May;117:52-9. doi: 10.1016/j.antiviral.2015.02.012. Epub 2015 Mar 6.

PMID:
25752738
3.

Therapeutic activity of intramuscular peramivir in mice infected with a recombinant influenza A/WSN/33 (H1N1) virus containing the H275Y neuraminidase mutation.

Abed Y, Pizzorno A, Boivin G.

Antimicrob Agents Chemother. 2012 Aug;56(8):4375-80. doi: 10.1128/AAC.00753-12. Epub 2012 Jun 4.

4.

Anti-influenza virus activity of peramivir in mice with single intramuscular injection.

Bantia S, Arnold CS, Parker CD, Upshaw R, Chand P.

Antiviral Res. 2006 Jan;69(1):39-45. Epub 2005 Nov 21.

PMID:
16325932
5.

Prophylactic activity of intramuscular peramivir in mice infected with a recombinant influenza A/WSN/33 (H1N1) virus containing the H274Y neuraminidase mutation.

Abed Y, Simon P, Boivin G.

Antimicrob Agents Chemother. 2010 Jul;54(7):2819-22. doi: 10.1128/AAC.01681-09. Epub 2010 Apr 19.

6.

Combinations of favipiravir and peramivir for the treatment of pandemic influenza A/California/04/2009 (H1N1) virus infections in mice.

Tarbet EB, Maekawa M, Furuta Y, Babu YS, Morrey JD, Smee DF.

Antiviral Res. 2012 Apr;94(1):103-10. doi: 10.1016/j.antiviral.2012.03.001. Epub 2012 Mar 10.

7.

Efficacy of repeated intravenous injection of peramivir against influenza A (H1N1) 2009 virus infection in immunosuppressed mice.

Kitano M, Kodama M, Itoh Y, Kanazu T, Kobayashi M, Yoshida R, Sato A.

Antimicrob Agents Chemother. 2013 May;57(5):2286-94. doi: 10.1128/AAC.02324-12. Epub 2013 Mar 11.

8.

Combinations of oseltamivir and peramivir for the treatment of influenza A (H1N1) virus infections in cell culture and in mice.

Smee DF, Hurst BL, Wong MH, Tarbet EB, Babu YS, Klumpp K, Morrey JD.

Antiviral Res. 2010 Oct;88(1):38-44. doi: 10.1016/j.antiviral.2010.07.003. Epub 2010 Jul 13.

9.

The effect of intravenous peramivir, compared with oral oseltamivir, on the outcome of post-influenza pneumococcal pneumonia in mice.

Tanaka A, Nakamura S, Seki M, Iwanaga N, Kajihara T, Kitano M, Homma T, Kurihara S, Imamura Y, Miyazaki T, Izumikawa K, Kakeya H, Yanagihara K, Kohno S.

Antivir Ther. 2015;20(1):11-9. doi: 10.3851/IMP2744. Epub 2014 Feb 12.

PMID:
24517996
10.

Efficacy of delayed treatment of China-made Peramivir with repeated intravenous injections in a mouse influenza model: from clinical experience to basal experiment.

Li Z, Li R, Li J, Xie H, Hao Y, Du Q, Chen T, Li Y, Chen R, Yang Z, Zhong N.

BMC Infect Dis. 2016 Jul 8;16:325. doi: 10.1186/s12879-016-1589-9.

11.

Combination of peramivir and rimantadine demonstrate synergistic antiviral effects in sub-lethal influenza A (H3N2) virus mouse model.

Bantia S, Kellogg D, Parker CD, Babu YS.

Antiviral Res. 2010 Dec;88(3):276-80. doi: 10.1016/j.antiviral.2010.09.020. Epub 2010 Oct 11.

PMID:
20943201
12.

Intramuscularly administered neuraminidase inhibitor peramivir is effective against lethal H5N1 influenza virus in mice.

Boltz DA, Ilyushina NA, Arnold CS, Babu YS, Webster RG, Govorkova EA.

Antiviral Res. 2008 Nov;80(2):150-7. doi: 10.1016/j.antiviral.2008.05.012. Epub 2008 Jun 23.

13.

Injectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus, A/Vietnam/1203/04 (H5N1).

Yun NE, Linde NS, Zacks MA, Barr IG, Hurt AC, Smith JN, Dziuba N, Holbrook MR, Zhang L, Kilpatrick JM, Arnold CS, Paessler S.

Virology. 2008 Apr 25;374(1):198-209. doi: 10.1016/j.virol.2007.12.029. Epub 2008 Jan 29.

14.

In vitro and in vivo efficacy of fluorodeoxycytidine analogs against highly pathogenic avian influenza H5N1, seasonal, and pandemic H1N1 virus infections.

Kumaki Y, Day CW, Smee DF, Morrey JD, Barnard DL.

Antiviral Res. 2011 Nov;92(2):329-40. doi: 10.1016/j.antiviral.2011.09.001. Epub 2011 Sep 8.

15.

Evaluation of methyl inosine monophosphate (MIMP) and peramivir activities in a murine model of lethal influenza A virus infection.

Mishin VP, Hayden FG, Signorelli KL, Gubareva LV.

Antiviral Res. 2006 Aug;71(1):64-8. Epub 2006 Mar 9.

PMID:
16581141
16.

Efficacy of single intravenous injection of peramivir against influenza B virus infection in ferrets and cynomolgus macaques.

Kitano M, Itoh Y, Kodama M, Ishigaki H, Nakayama M, Ishida H, Baba K, Noda T, Sato K, Nihashi Y, Kanazu T, Yoshida R, Torii R, Sato A, Ogasawara K.

Antimicrob Agents Chemother. 2011 Nov;55(11):4961-70. doi: 10.1128/AAC.00412-11. Epub 2011 Aug 15.

17.

Clinical experience in adults and children treated with intravenous peramivir for 2009 influenza A (H1N1) under an Emergency IND program in the United States.

Hernandez JE, Adiga R, Armstrong R, Bazan J, Bonilla H, Bradley J, Dretler R, Ison MG, Mangino JE, Maroushek S, Shetty AK, Wald A, Ziebold C, Elder J, Hollister AS, Sheridan W; eIND Peramivir Investigators.

Clin Infect Dis. 2011 Mar 15;52(6):695-706. doi: 10.1093/cid/cir001.

18.

Combination effects of peramivir and favipiravir against oseltamivir-resistant 2009 pandemic influenza A(H1N1) infection in mice.

Park S, Kim JI, Lee I, Lee S, Hwang MW, Bae JY, Heo J, Kim D, Jang SI, Kim H, Cheong HJ, Song JW, Song KJ, Baek LJ, Park MS.

PLoS One. 2014 Jul 3;9(7):e101325. doi: 10.1371/journal.pone.0101325. eCollection 2014.

19.

Assessment of Antiviral Properties of Peramivir against H7N9 Avian Influenza Virus in an Experimental Mouse Model.

Farooqui A, Huang L, Wu S, Cai Y, Su M, Lin P, Chen W, Fang X, Zhang L, Liu Y, Zeng T, Paquette SG, Khan A, Kelvin AA, Kelvin DJ.

Antimicrob Agents Chemother. 2015 Dec;59(12):7255-64. doi: 10.1128/AAC.01885-15. Epub 2015 Sep 14.

20.

Assessment of the efficacy of the neuraminidase inhibitor oseltamivir against 2009 pandemic H1N1 influenza virus in ferrets.

Govorkova EA, Marathe BM, Prevost A, Rehg JE, Webster RG.

Antiviral Res. 2011 Aug;91(2):81-8. doi: 10.1016/j.antiviral.2011.05.008. Epub 2011 May 27.

Supplemental Content

Support Center